Hemab
Hemab Therapeutics is pioneering the first preventative treatments for rare bleeding and thrombotic disorders to ensure no patient is ever left behind
3
Funding Rounds
$250.0m
Money raised
Overview
Hemab Therapeutics is pioneering the first preventative treatments for rare bleeding and thrombotic disorders to ensure no patient is ever left behind
-
Website:
- Business model: B2B
- Headquarters: Copenhagen
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Hemab has raised a total of $250m in funding over 3 rounds.
Key Insights:
- Hemab February 2023 Series B Funding Round: $140m
- Hemab Series A round, July 2021: $55m
- Hemab July 2021 Series A Funding Round: $55m
Hemab February 2023 Series B Funding Round
$140m
Hemab Series A round, July 2021
$55m
Hemab July 2021 Series A Funding Round
$55m
Industries
Hemab is active in the following industries: